CXCL9 and rheumatoid arthritis: Also, the plasma levels of CXCL9 were significantly higher in the early and late RA patients relative to the controls, as well as in the early RA relative to late RA patients (p < 0.0001, p < 0.001 and p < 0.001, in order) (Table 2).